Dr. Mahvish Muzaffar
Claim this profileEast Carolina University
Studies Breast Cancer
Studies Colorectal Cancer
9 reported clinical trials
26 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
ER negative
PR negative
2Colorectal Cancer
Stage IV
Stage III
dMMR negative
Affiliated Hospitals
Clinical Trials Mahvish Muzaffar is currently running
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Mahvish Muzaffar
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mahvish Muzaffar has experience with
- Biospecimen Collection
- Fluorouracil
- Questionnaire Administration
- Leucovorin Calcium
- Irinotecan Hydrochloride
- Irinotecan
Breakdown of trials Mahvish Muzaffar has run
Breast Cancer
Colorectal Cancer
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mahvish Muzaffar specialize in?
Mahvish Muzaffar focuses on Breast Cancer and Colorectal Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are ER negative.
Is Mahvish Muzaffar currently recruiting for clinical trials?
Yes, Mahvish Muzaffar is currently recruiting for 2 clinical trials in Greenville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Mahvish Muzaffar has studied deeply?
Yes, Mahvish Muzaffar has studied treatments such as Biospecimen Collection, Fluorouracil, Questionnaire Administration.
What is the best way to schedule an appointment with Mahvish Muzaffar?
Apply for one of the trials that Mahvish Muzaffar is conducting.
What is the office address of Mahvish Muzaffar?
The office of Mahvish Muzaffar is located at: East Carolina University, Greenville, North Carolina 27834 United States. This is the address for their practice at the East Carolina University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.